{"title":"Inulin Induced Co-Aggregation of Saccharomyces boulardii with Potential Pathogenic Bacteria","authors":"G. Reya, Chakraborty Ritun, Sarkar Kasturi","doi":"10.37290/ijpp2641-7197.14:18-23","DOIUrl":null,"url":null,"abstract":"The synbiotic potential of Saccharomyces boulardii and inulin was evaluated on mice gut microflora. The number of microorganisms in the feces of mice treated with the synbiotic combination or Saccharomyces boulardii/inulin alone was found to be less compared to the normal control. S. boulardii grown in presence of inulin was found to interact and form aggregation with Escherichia coli and Enterococcus faecalis in vitro though the same interaction pattern was not seen with Staphylococcus aureus, Lactobacillus casei, Lactobacillus rhamnosus and Lactobacillus plantarum. Aggregate was not found between E. coli/E. faecalis and S. boularii when the later was grown in prebiotics like maltodextrin and fructooligosaccharide. All the microorganisms were found to be alive in the aggregate and heat treatment of S. boulardii completely abolished the aggregation property. There was no biofilm formation in the aggregate and inhibition of protein synthesis resulted in no aggregation with E. coli/E. faecalis. Removal of the effect of cycloheximide from S. boulardii restored back the aggregation in presence of inulin. Thus, the decreased number of microorganisms in feces might be a result of aggregate formation between S. boulardii and E. coli/E. faecalis in presence of inulin and subsequent elimination from gut through mucus.","PeriodicalId":53704,"journal":{"name":"International Journal of Probiotics and Prebiotics","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Probiotics and Prebiotics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37290/ijpp2641-7197.14:18-23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3
Abstract
The synbiotic potential of Saccharomyces boulardii and inulin was evaluated on mice gut microflora. The number of microorganisms in the feces of mice treated with the synbiotic combination or Saccharomyces boulardii/inulin alone was found to be less compared to the normal control. S. boulardii grown in presence of inulin was found to interact and form aggregation with Escherichia coli and Enterococcus faecalis in vitro though the same interaction pattern was not seen with Staphylococcus aureus, Lactobacillus casei, Lactobacillus rhamnosus and Lactobacillus plantarum. Aggregate was not found between E. coli/E. faecalis and S. boularii when the later was grown in prebiotics like maltodextrin and fructooligosaccharide. All the microorganisms were found to be alive in the aggregate and heat treatment of S. boulardii completely abolished the aggregation property. There was no biofilm formation in the aggregate and inhibition of protein synthesis resulted in no aggregation with E. coli/E. faecalis. Removal of the effect of cycloheximide from S. boulardii restored back the aggregation in presence of inulin. Thus, the decreased number of microorganisms in feces might be a result of aggregate formation between S. boulardii and E. coli/E. faecalis in presence of inulin and subsequent elimination from gut through mucus.
期刊介绍:
The International journal of Probiotics & Prebiotics publishes on online only in an open access format. This is a broad based international, interdisciplinary peer reviewed scientific journal for critical evaluation of research on prebiotics, probiotics and synbiotics. The major goal of this journal is to provide unbiased scientific data to students, researchers, healthcare providers, and the decision makers in the nutraceutical industry to help make informed choices about prebiotics, probiotics and synbiotics. To this end, the journal will publish original research articles and two types of review articles. First, we will publish a review of preclinical research data coming largely from animal, cell culture and other experimental models. Such data will provide basis for future product development and/or human research initiatives. Second, we will publish a critical evaluation of current human experimental data to help deliver products with medically proven use.